SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-372144
Filing Date
2015-11-09
Accepted
2015-11-09 17:15:32
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d97716d10q.htm 10-Q 374929
2 EXHIBIT 31.1 d97716dex311.htm EX-31.1 8155
3 EXHIBIT 31.2 d97716dex312.htm EX-31.2 8138
4 EXHIBIT 32.1 d97716dex321.htm EX-32.1 3902
  Complete submission text file 0001193125-15-372144.txt   2541627

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cara-20150930.xml EX-101.INS 352864
6 XBRL TAXONOMY EXTENSION SCHEMA cara-20150930.xsd EX-101.SCH 37060
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cara-20150930_cal.xml EX-101.CAL 47352
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cara-20150930_def.xml EX-101.DEF 113183
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20150930_lab.xml EX-101.LAB 293649
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20150930_pre.xml EX-101.PRE 206616
Mailing Address ONE PARROTT DRIVE SHELTON CT 06484
Business Address ONE PARROTT DRIVE SHELTON CT 06484 203-567-1500
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 151216676
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences